James Mitchell

3.5k total citations · 1 hit paper
56 papers, 1.4k citations indexed

About

James Mitchell is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism and Ophthalmology. According to data from OpenAlex, James Mitchell has authored 56 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 16 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Ophthalmology. Recurrent topics in James Mitchell's work include Cerebral Venous Sinus Thrombosis (37 papers), Pituitary Gland Disorders and Treatments (16 papers) and Glaucoma and retinal disorders (12 papers). James Mitchell is often cited by papers focused on Cerebral Venous Sinus Thrombosis (37 papers), Pituitary Gland Disorders and Treatments (16 papers) and Glaucoma and retinal disorders (12 papers). James Mitchell collaborates with scholars based in United Kingdom, United States and Australia. James Mitchell's co-authors include Alexandra J. Sinclair, Susan P. Mollan, Andreas Yiangou, Hannah Botfield, Connar Stanley James Westgate, Zerin Alimajstorovic, Keira Markey, Yusuf A. Rajabally, Guillaume Nicolas and Marie‐Christine Durand and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

James Mitchell

50 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

2023 72 citations James Mitchell, Hannah Lyons et al. Brain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Mitchell United Kingdom	24	1.1k	444	260	220	185	56	1.4k
Weihua Meng United Kingdom	17	88 0.1×	255 0.6×	175 0.7×	129 0.6×	57 0.3×	44	1.0k
Johannes Steinberg Germany	18	76 0.1×	469 1.1×	32 0.1×	172 0.8×	47 0.3×	81	1.3k
M T Shokunbi Nigeria	18	351 0.3×	45 0.1×	46 0.2×	18 0.1×	238 1.3×	104	1.0k
Sanja Ilic Serbia	14	41 0.0×	31 0.1×	189 0.7×	107 0.5×	158 0.9×	44	1.2k
Deena E. Kuruvilla United States	10	609 0.6×	51 0.1×	11 0.0×	316 1.4×	27 0.1×	28	1.0k
Kara Melmed United States	17	725 0.7×	61 0.1×	20 0.1×	73 0.3×	80 0.4×	55	1.1k
Viggo Kamp Nielsen Denmark	14	809 0.8×	20 0.0×	175 0.7×	63 0.3×	89 0.5×	22	1.2k
Şeref Demirkaya Türkiye	14	103 0.1×	89 0.2×	28 0.1×	172 0.8×	22 0.1×	54	698
C M Shaw United States	19	191 0.2×	66 0.1×	59 0.2×	102 0.5×	134 0.7×	36	928
Bartosz T. Grobelny United States	19	1.1k 1.1×	9 0.0×	105 0.4×	82 0.4×	162 0.9×	36	1.7k

Countries citing papers authored by James Mitchell

Since Specialization

Citations

This map shows the geographic impact of James Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Mitchell more than expected).

Fields of papers citing papers by James Mitchell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Mitchell. The network helps show where James Mitchell may publish in the future.

Co-authorship network of co-authors of James Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of James Mitchell. A scholar is included among the top collaborators of James Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Mitchell. James Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mitchell, James, Hannah Lyons, Jessica Walker, et al.. (2025). A randomized sequential cross‐over trial evaluating five purportedly ICP ‐lowering drugs in idiopathic intracranial hypertension. Headache The Journal of Head and Face Pain. 65(2). 258–268. 5 indexed citations

Lyons, Hannah, Matilde Sassani, Mark Thaller, et al.. (2024). Evaluating the Phenotypic Patterns of Post-Traumatic Headache: A Systematic Review of Military Personnel. Military Medicine. 190(1-2). e90–e98. 2 indexed citations

Grech, Olivia, James Mitchell, Hannah Lyons, et al.. (2024). Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial Hypertension. Eye. 38(7). 1374–1379. 17 indexed citations

Mitchell, James, Hannah Lyons, Jessica Walker, et al.. (2023). The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 146(5). 1821–1830. 72 indexed citations breakdown →

Yiangou, Andreas, Mark Thaller, James Mitchell, et al.. (2023). The Impact of Valsalva Manoeuvres and Exercise on Intracranial Pressure and Cerebrovascular Dynamics in Idiopathic Intracranial Hypertension. Neuro-Ophthalmology. 48(2). 122–133. 5 indexed citations

Alimajstorovic, Zerin, James Mitchell, Andreas Yiangou, et al.. (2023). Determining the role of novel metabolic pathways in driving intracranial pressure reduction after weight loss. Brain Communications. 5(5). fcad272–fcad272. 13 indexed citations

Mitchell, James, Hannah Lyons, Jessica Walker, et al.. (2022). Evaluation of diurnal and postural intracranial pressure employing telemetric monitoring in idiopathic intracranial hypertension. Fluids and Barriers of the CNS. 19(1). 85–85. 20 indexed citations

Alimajstorovic, Zerin, Susan P. Mollan, Olivia Grech, et al.. (2022). Dysregulation of Amino Acid, Lipid, and Acylpyruvate Metabolism in Idiopathic Intracranial Hypertension: A Non-targeted Case Control and Longitudinal Metabolomic Study. Journal of Proteome Research. 22(4). 1127–1137. 9 indexed citations

Holdsworth, David, Robert Barker‐Davies, Oliver O’Sullivan, et al.. (2022). Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLoS ONE. 17(6). e0267392–e0267392. 41 indexed citations

10.

Grech, Olivia, Andrew Clouter, James Mitchell, et al.. (2021). Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure. Brain Communications. 3(3). fcab202–fcab202. 39 indexed citations

11.

Yiangou, Andreas, James Mitchell, Yu Jeat Chong, et al.. (2021). Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT). Journal of Neurology. 269(4). 1945–1956. 28 indexed citations

12.

Westgate, Connar Stanley James, Hannah Botfield, Zerin Alimajstorovic, et al.. (2021). Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 6(10). 50 indexed citations

13.

Mitchell, James, Susan P. Mollan, Georgios Tsermoulas, & Alexandra J. Sinclair. (2021). Telemetric monitoring in idiopathic intracranial hypertension demonstrates intracranial pressure in a case with sight-threatening disease. Acta Neurochirurgica. 163(3). 725–731. 8 indexed citations

14.

Yiangou, Andreas, James Mitchell, Julie Edwards, et al.. (2020). Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation. Headache The Journal of Head and Face Pain. 61(1). 157–169. 37 indexed citations

15.

Alimajstorovic, Zerin, Connar Stanley James Westgate, Rigmor Jensen, et al.. (2020). Guide to preclinical models used to study the pathophysiology of idiopathic intracranial hypertension. Eye. 34(8). 1321–1333. 10 indexed citations

16.

O’Reilly, Michael, Connar Stanley James Westgate, Catherine Hornby, et al.. (2019). A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 4(6). 90 indexed citations

17.

Scotton, William J., Hannah Botfield, Connar Stanley James Westgate, et al.. (2018). Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 39(2). 209–218. 61 indexed citations

18.

Ottridge, Ryan, Susan P. Mollan, Hannah Botfield, et al.. (2017). Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol. BMJ Open. 7(9). e017426–e017426. 54 indexed citations

19.

Botfield, Hannah, Maria Uldall, Connar Stanley James Westgate, et al.. (2017). A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Science Translational Medicine. 9(404). 94 indexed citations

20.

Markey, Keira, Ryan Ottridge, James Mitchell, et al.. (2017). Assessing the Efficacy and Safety of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial. JMIR Research Protocols. 6(9). e181–e181. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact